Literature DB >> 20872077

Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT.

Jing Gu1, Pek-Lan Khong, Silun Wang, Queenie Chan, Wailun Law, Jingbo Zhang.   

Abstract

PURPOSE: The aim of the study was to assess correlations between parameters on diffusion-weighted imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in rectal cancer. PROCEDURES: Thirty-three consecutive patients with pathologically confirmed rectal adenocarcinoma were included in this study. Apparent diffusion coefficient (ADC) maps were generated to calculate ADC(mean) (average ADC), ADC(min) (lowest ADC), tumor volume, and total diffusivity index (TDI). PET/CT exams were performed within 1 week of magnetic resonance imaging. Standardized uptake values (SUVs) were normalized to the injected FDG dose and body weight. SUV(max) (maximum SUV), SUV(mean) (average SUV), tumor volume, and total lesion glycolysis (TLG) were calculated using a 50% threshold.
RESULTS: Significant negative correlations were found between ADC(min) and SUV(max) (r = -0.450, p = 0.009), and between ADC(mean) and SUV(mean) (r = -0.402, p = 0.020). A significant positive correlation was found between TDI and TLG (r = 0.634, p < 0.001).
CONCLUSION: The significant negative correlations between ADC and SUV suggest an association between tumor cellularity and metabolic activity in primary rectal adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872077      PMCID: PMC3179585          DOI: 10.1007/s11307-010-0433-7

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  46 in total

1.  FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.

Authors:  K L Berger; S A Nicholson; F Dehdashti; B A Siegel
Journal:  AJR Am J Roentgenol       Date:  2000-04       Impact factor: 3.959

2.  Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity.

Authors:  T Kuwert; S Probst-Cousin; B Woesler; C Morgenroth; H Lerch; P Matheja; S Palkovic; M Schäfers; H Wassmann; F Gullotta; O Schober
Journal:  J Nucl Med       Date:  1997-10       Impact factor: 10.057

Review 3.  Positron emission tomography application for gynecologic tumors.

Authors:  Y Nakamoto; T Saga; S Fujii
Journal:  Int J Gynecol Cancer       Date:  2005 Sep-Oct       Impact factor: 3.437

4.  Localized form of bronchioloalveolar carcinoma: FDG PET findings.

Authors:  B T Kim; Y Kim; K S Lee; S B Yoon; E M Cheon; O J Kwon; C H Rhee; J Han; M H Shin
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

5.  Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization.

Authors:  Andreas M Herneth; Samira Guccione; Mark Bednarski
Journal:  Eur J Radiol       Date:  2003-03       Impact factor: 3.528

6.  18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?

Authors:  Kenneth J Biehl; Feng-Ming Kong; Farrokh Dehdashti; Jian-Yue Jin; Sasa Mutic; Issam El Naqa; Barry A Siegel; Jeffrey D Bradley
Journal:  J Nucl Med       Date:  2006-11       Impact factor: 10.057

7.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

8.  Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection.

Authors:  Einat Even-Sapir; Yoav Parag; Hedva Lerman; Mordechai Gutman; Charles Levine; Micha Rabau; Arie Figer; Ur Metser
Journal:  Radiology       Date:  2004-07-23       Impact factor: 11.105

9.  PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

Authors:  Florian Lordick; Katja Ott; Bernd-Joachim Krause; Wolfgang A Weber; Karen Becker; Hubert J Stein; Sylvie Lorenzen; Tibor Schuster; Hinrich Wieder; Ken Herrmann; Rainer Bredenkamp; Heinz Höfler; Ulrich Fink; Christian Peschel; Markus Schwaiger; Jörg R Siewert
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

10.  Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer.

Authors:  Shigeto Ueda; Nobuo Kondoh; Hitoshi Tsuda; Souhei Yamamoto; Hideki Asakawa; Kazuhiko Fukatsu; Takayuki Kobayashi; Junji Yamamoto; Katsumi Tamura; Jiro Ishida; Yoshiyuki Abe; Mikio Yamamoto; Hidetaka Mochizuki
Journal:  BMC Cancer       Date:  2008-12-22       Impact factor: 4.430

View more
  35 in total

Review 1.  [The role of cross-sectional imaging in staging of rectal cancer].

Authors:  A O Schäfer; M Langer; T Baumann
Journal:  Chirurg       Date:  2012-05       Impact factor: 0.955

2.  Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer.

Authors:  Davide Ippolito; Davide Fior; Chiara Trattenero; Elena De Ponti; Silvia Drago; Luca Guerra; Cammillo Talei Franzesi; Sandro Sironi
Journal:  World J Radiol       Date:  2015-12-28

3.  PET/MRI Radiomics in Rectal Cancer: a Pilot Study on the Correlation Between PET- and MRI-Derived Image Features with a Clinical Interpretation.

Authors:  Barbara Juarez Amorim; Angel Torrado-Carvajal; Shadi A Esfahani; Sara S Marcos; Mark Vangel; Dan Stein; David Groshar; Onofrio A Catalano
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

4.  Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla.

Authors:  Julia Fruehwald-Pallamar; Christian Czerny; Marius E Mayerhoefer; Benjamin S Halpern; Christina Eder-Czembirek; Markus Brunner; Matthias Schuetz; Michael Weber; Laura Fruehwald; Andreas M Herneth
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-05       Impact factor: 9.236

5.  FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.

Authors:  Vasavi Paidpally; Alin Chirindel; Stella Lam; Nishant Agrawal; Harry Quon; Rathan M Subramaniam
Journal:  Imaging Med       Date:  2012-12

6.  Radiation induced brain injury: assessment of white matter tracts in a pre-clinical animal model using diffusion tensor MR imaging.

Authors:  Silun Wang; Deqiang Qiu; Kwok-Fai So; Ed X Wu; Lucullus H T Leung; Jing Gu; Pek-Lan Khong
Journal:  J Neurooncol       Date:  2013-01-20       Impact factor: 4.130

Review 7.  Diffusion-weighted imaging of the liver: techniques and applications.

Authors:  Sara Lewis; Hadrien Dyvorne; Yong Cui; Bachir Taouli
Journal:  Magn Reson Imaging Clin N Am       Date:  2014-08       Impact factor: 2.266

8.  Correlation of minimum apparent diffusion coefficient with maximum standardized uptake on fluorodeoxyglucose PET-CT in patients with rectal adenocarcinoma.

Authors:  Hale Çolakoğlu Er; Ayşe Erden; N Özlem Küçük; Ethem Geçim
Journal:  Diagn Interv Radiol       Date:  2014 Mar-Apr       Impact factor: 2.630

9.  Quantitating whole lesion tumor biology in rectal cancer MRI: taking a lesson from FDG-PET tumor metrics.

Authors:  Marc J Gollub; Andreas M Hotker; Kaitlin M Woo; Yousef Mazaheri; Mithat Gonen
Journal:  Abdom Radiol (NY)       Date:  2018-07

10.  Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer.

Authors:  Barbara J Amorim; Vinay Prabhu; Sara S Marco; Debra Gervais; Willian E Palmer; Pedram Heidari; Mark Vangel; Philip J Saylor; Onofrio A Catalano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-06       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.